• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[对接受化疗的癌症门诊患者手足综合征的评估]

[Assessment of hand-foot syndrome in cancer outpatients undergoing chemotherapy].

作者信息

Takeda Keiko, Shigematsu Tadashi, Shirai Masahiro, Yamagiwa Kouhei, Amamori Keiko, Sunda Kazumi, Yamanda Toshimi

机构信息

Dept. of Pharmacy, Saiseikai Shigaken Hospital.

出版信息

Gan To Kagaku Ryoho. 2012 Dec;39 Suppl 1:74-6.

PMID:23268906
Abstract

Capecitabine, an oral prodrug of 5 -fluorouracil, is a promising treatment for colorectal, breast, and gastric cancers, but often causes hand-foot syndrome(HFS), which is the most common dose-limiting toxicity. The aim of this study was to evaluate of the efficacy of the pharmacist in providing support at ambulatory therapy centers, especially for HFS. The HFS is a higher-incidence adverse event that may develop during chemotherapy with capecitabine. Once developed, the symptoms significantly impair quality of life(QOL), leading to a reduction in the dosage or discontinuation of the treatment. Patient symptoms may therefore increase in severity. This study was performed to analyze the treatment adherence and adverse events resulting from capecitabine therapy provided by pharmacists to cancer outpatients. All patients were prescribed vitamin B6(pyridoxine), which can help to reduce or prevent HFS. A lesser or milder extent of HFS was detected in patients who had used a moisturizer at the same time as the introduction of capecitabine therapy. Adherence to this approach will benefit the patients' selfcare in maintaining moisture retention, which is an important countermeasure for HFS. Additionally, early introduction of effective countermeasures for skin care, dose reduction, and rest periods is important for HFS management; in addition, team care support is dispensable. Our support system may be useful for management strategies for HFS. We suggest that improved quality of lif e is needed in cancer outpatients being treated with chemotherapy.

摘要

卡培他滨是5-氟尿嘧啶的口服前体药物,是一种有前景的用于治疗结直肠癌、乳腺癌和胃癌的药物,但常引起手足综合征(HFS),这是最常见的剂量限制性毒性。本研究的目的是评估药剂师在门诊治疗中心提供支持的效果,尤其是针对手足综合征。手足综合征是在使用卡培他滨化疗期间可能发生的一种高发性不良事件。一旦发生,这些症状会显著损害生活质量(QOL),导致剂量减少或治疗中断。因此患者症状的严重程度可能会增加。本研究旨在分析药剂师为癌症门诊患者提供的卡培他滨治疗所导致的治疗依从性和不良事件。所有患者均被开具维生素B6(吡哆醇),其有助于减轻或预防手足综合征。在卡培他滨治疗开始时同时使用保湿剂的患者中,检测到的手足综合征程度较轻或较缓和。坚持这种方法将有利于患者在保持皮肤水分方面的自我护理,这是应对手足综合征的一项重要对策。此外,早期引入有效的皮肤护理、剂量减少和休息期对策对于手足综合征的管理很重要;此外,团队护理支持是必不可少的。我们的支持系统可能对手足综合征的管理策略有用。我们建议,接受化疗的癌症门诊患者需要提高生活质量。

相似文献

1
[Assessment of hand-foot syndrome in cancer outpatients undergoing chemotherapy].[对接受化疗的癌症门诊患者手足综合征的评估]
Gan To Kagaku Ryoho. 2012 Dec;39 Suppl 1:74-6.
2
[Assessment of hand-foot syndrome in cancer patients treated with capecitabine-containing chemotherapy].[接受含卡培他滨化疗的癌症患者手足综合征的评估]
Gan To Kagaku Ryoho. 2013 Dec;40 Suppl 2:161-3.
3
[Management of hand-foot syndrome in patient treated with capecitabine].[卡培他滨治疗患者的手足综合征管理]
Gan To Kagaku Ryoho. 2008 Aug;35(8):1357-60.
4
[Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients].口服卡培他滨用于Ⅲ期结肠癌患者术后辅助化疗
Gan To Kagaku Ryoho. 2012 Mar;39(3):389-93.
5
Impact of prophylactic pyridoxine on occurrence of hand-foot syndrome in patients receiving capecitabine for advanced or metastatic breast cancer.预防性补充吡哆醇对接受卡培他滨治疗的晚期或转移性乳腺癌患者手足综合征发生的影响。
Breast Cancer. 2010 Oct;17(4):298-302. doi: 10.1007/s12282-009-0171-3. Epub 2009 Sep 30.
6
Management of hand-foot syndrome induced by capecitabine.卡培他滨所致手足综合征的管理
J Oncol Pharm Pract. 2006 Sep;12(3):131-41. doi: 10.1177/1078155206069242.
7
Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study.吡哆醇预防卡培他滨治疗相关性手足综合征的疗效:一项随机、双盲、安慰剂对照研究的结果。
J Clin Oncol. 2010 Aug 20;28(24):3824-9. doi: 10.1200/JCO.2010.29.1807. Epub 2010 Jul 12.
8
Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-Associated Hand-Foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working Group.卡培他滨相关性手足综合征的预防性治疗:AIO 生活质量工作组的一项多中心 III 期随机试验,比较 MAPISAL 乳膏和尿素乳膏。
J Clin Oncol. 2015 Aug 1;33(22):2444-9. doi: 10.1200/JCO.2014.60.4587. Epub 2015 Jun 29.
9
Self-identification and management of hand-foot syndrome (HFS): effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for colon cancer.手足综合征(HFS)的自我识别与管理:结构化教学计划对接受基于卡培他滨的结肠癌化疗患者的影响
Support Care Cancer. 2016 Jun;24(6):2575-81. doi: 10.1007/s00520-015-3061-6. Epub 2015 Dec 30.
10
Management of hand-foot syndrome in patients treated with capecitabine (Xeloda).卡培他滨(希罗达)治疗患者的手足综合征管理
Eur J Oncol Nurs. 2004;8 Suppl 1:S31-40. doi: 10.1016/j.ejon.2004.06.007.

引用本文的文献

1
Pharmacist Intervention in Outpatients With Prostate Cancer Prevents Apalutamide-induced Skin Adverse Events.药剂师对前列腺癌门诊患者的干预可预防阿帕鲁胺引起的皮肤不良事件。
In Vivo. 2025 Jan-Feb;39(1):459-466. doi: 10.21873/invivo.13849.
2
Self-identification and management of hand-foot syndrome (HFS): effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for colon cancer.手足综合征(HFS)的自我识别与管理:结构化教学计划对接受基于卡培他滨的结肠癌化疗患者的影响
Support Care Cancer. 2016 Jun;24(6):2575-81. doi: 10.1007/s00520-015-3061-6. Epub 2015 Dec 30.